know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

ENDO 2022 is a Wrap!

May 31, 2022

Thank you to all the attendees, speakers, and sponsors that joined us for ENDO 2022 both in-person and online. We were thrilled to welcome so many familiar faces, and many new ones, for our program in Atlanta and online. We look forward to seeing you again at ENDO 2023 June 15 - 18, 2022, in Chicago, IL!

Meetings & Events

Do Not Miss Our First-Class Program at CEU 2022

June 20, 2022

Join us on September 8-10 to discover the latest developments in endocrinology diagnosis and treatments. This year, we are excited to announce our first CEU hybrid experience! For the first time since 2019, we will return to the in-person meeting at the Intercontinental Hotel in Miami, FL. Additionally, our entire program will also be available online. Register by July 28 to secure the lowest rates. Sign up today!

Clinical Practice Guideline

New Inpatient Hyperglycemia Guideline Resources

June 11, 2022

We are pleased to announce the release of our latest clinical practice guideline: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings! This new guideline reflects evolving clinical science and provides evidence-based recommendations for clinical care and practice managing hyperglycemia in the inpatient setting.

Training & Education

Now Available: 2022 Endocrine Case Management: Meet the Professor e-book

June 22, 2022

We are pleased to introduce the 2022 Endocrine Case Management: Meet the Professor E-Book! This comprehensive educational resource is designed to provide endocrinologists with a high-quality, concise review of common and rare endocrine disorders. Our E-Book will give you access to case-based vignettes and rationales to learn the nuances of patient care from over 35 experts in all areas of endocrinology, diabetes, and metabolism.


Advocacy in Action

June 23, 2022

The Endocrine Society endorses the INSULIN Act and urges Congress to pass this legislation as soon as possible.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Endocrine Society urges Congress to pass bill to make insulin more affordable for people with diabetes

June 23, 2022

The Endocrine Society announces its endorsement of the bipartisan insulin bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) that would take steps to reduce out-of-pocket costs of insulin, the escalating price of insulin, and formulary management for people with diabetes.

Study finds disparities in access to insulin pumps among youth with type 1 diabetes

June 14, 2022

Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Growth hormone improves liver health in people with nonalcoholic fatty liver disease

June 14, 2022

Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

View More

Featured Journal Articles

Novel PTH Gene Mutations and Hypoparathyroidism

June 21, 2022

Through describing 2 novel mutations of the parathyroid hormone gene, we aim to extend the molecular basis for familial isolated hypoparathyroidism and further refine the proposed mechanisms by which PTH mutations cause hypoparathyroidism.

Update on Adrenocortical Carcinomas: Biology, Genomics, Therapies

June 21, 2022

A comprehensive, integrated, and current bench-to-bedside understanding of our field’s investigations into adrenocortical physiology and neoplasia is crucial to developing novel clinical tools and approaches to equip the one-in-a-million patient fighting this devastating disease.

Intrauterine Therapy Normalizes Glucose Metabolism

June 21, 2022

To date, prenatal treatments for fetal growth restriction (FGR) have not attempted to correct oxygen and glucose supply simultaneously, so we investigated whether a 5-day correction of oxygen and glucose concentrations in placental insufficiency-FGR fetuses would normalize insulin secretion and glucose metabolism.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.